← FDA Drug Approvals (Drugs@FDA)

AMLODIPINE AND OLMESARTAN MEDOXOMIL

ANDA · Abbreviated New Drug Application (Generic) · Sponsor: JUBILANT GENERICS · Approved 2017-05-15

Drug application

FDA Application #

ANDA207450

Application type

Abbreviated New Drug Application (Generic)

Brand name

AMLODIPINE AND OLMESARTAN MEDOXOMIL

Generic name

Amlodipine Besylate

Active ingredients

AMLODIPINE BESYLATE; OLMESARTAN MEDOXOMIL

Dosage form

TABLET

Route

ORAL

Marketing status

Discontinued

Sponsor

JUBILANT GENERICS

First approval

2017-05-15

Source

Authoritative

Drugs@FDA application overview

Machine

JSON-LD · Markdown